Antimicrobial Agents: Present Situation and Prospects for the Future
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 2950
Special Issue Editor
Interests: biofilms; metallotherapeutic compounds; implant-associated infections; novel antimicrobial agents; reactive oxygen species; reactive nitrogen species; carbon monoxide and CO-releasing molecules
Special Issue Information
Dear Colleagues,
Over recent decades, there has been a significant increase in microbial infections that display multidrug resistance, leading to a concomitant increase in mortality rates. As last-line antimicrobial treatments increasingly fail, antimicrobial resistance is becoming an ever-increasing global threat to public health.
Metal complexes have demonstrated antimicrobial activity throughout recorded history; however, due to the wide range of effective conventional antibiotics developed for use since the early 1940s, these leads are mostly underdeveloped. With the current growing antibiotic resistance crisis and lack of development of new antibiotics, the use of metals as antimicrobials has gained popularity in recent years, raising the possibility that metal complexes can bring new life to antimicrobial drug discovery.
This Special Issue aims to gather papers describing the current use and future development of metal complexes as antimicrobial agents that are active against bacteria, fungi and viruses. We are also welcoming papers describing the discovery of novel targets and mechanisms of action and resistance, as well as the use of omic and bioinformatic approaches for the development of new metal-based antimicrobial leads.
In this Special Issue, original research articles and reviews are welcome.
I look forward to receiving your contributions.
Dr. Samantha McLeanGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metals
- novel antimicrobials
- infection
- drug discovery
- nanoparticles
- antimicrobial resistance
- drug delivery
- adjuvants
- synergy
